Inicio Zine News FDA Approves SCENESSE® For Genetic Disorder

FDA Approves SCENESSE® For Genetic Disorder

24
0
New drug approved by US regulatory authorities for metabolic disorder erythropoietic protoporphyria (EPP)
New drug approved by US regulatory authorities for metabolic disorder erythropoietic protoporphyria (EPP)